StockMarketWire.com - Oesophageal doppler monitoring company Deltex Medical reported a fall in revenue owing to the impact of COVID-19 and the associated significant reduction in elective surgical procedures worldwide.

For the year ended 31 December, revenue dropped to £2.4 million from £4.3 million year-on-year.

Cash as at 31 December 2020, stood at £0.9 million, unchanged from last year.






At 9:09am: [LON:DEMG] Deltex Medical Group PLC share price was 0p at 1.3p



Story provided by StockMarketWire.com